Cato Mørk

Author network for Cato Mørk by COREMINE medical

Publications 2017

Jørgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mørk C, Jahnsen J, Kvien TK, NOR-SWITCH study group (2017)
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
Lancet (in press)
PubMed 28502609

Publications 2015

Namer B, Ørstavik K, Schmidt R, Kleggetveit IP, Weidner C, Mørk C, Kvernebo MS, Kvernebo K, Salter H, Carr TH, Segerdahl M, Quiding H, Waxman SG, Handwerker HO, Torebjörk HE, Jørum E, Schmelz M (2015)
Specific changes in conduction velocity recovery cycles of single nociceptors in a patient with erythromelalgia with the I848T gain-of-function mutation of Nav1.7
Pain, 156 (9), 1637-46
PubMed 25993546

Publications 2014

Bergersen TK, Hoffmann-Vold AM, Midtvedt Ø, Gran JT, Mørk C, Toska K, Elstad M (2014)
Dysfunctional arteriovenous anastomoses in hands of systemic sclerosis patients with digital ulcers
Clin Exp Rheumatol, 32 (6 Suppl 86), S-53-9
PubMed 24847906

Heppner HJ, Singler K, Sieber C, Christ M, Bahrmann P, Mork C (2014)
[Requirements for perioperative intensive care of geriatric patients]
Z Gerontol Geriatr, 47 (2), 125-30
PubMed 24619043

Publications 2013

Ljosaa TM, Stubhaug A, Mork C, Moum T, Wahl AK (2013)
Improvement in Psoriasis Area and Severity Index score predicts improvement in skin pain over time in patients with psoriasis
Acta Derm Venereol, 93 (3), 330-4
PubMed 23007130

Seçkin D, Barete S, Euvrard S, Francès C, Kanitakis J, Geusau A, Del Marmol V, Harwood CA, Proby CM, Ali I, Güleç AT, Durukan E, Lebbé C, Alaibac M, Laffitte E, Cooper S, Bouwes Bavinck JN, Murphy GM, Ferrándiz C, Mørk C, Cetkovská P, Kempf W, Hofbauer GF (2013)
Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series
Am J Transplant, 13 (8), 2146-53
PubMed 23718915

Publications 2012

Christensen E, Mørk C, Skogvoll E (2012)
High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study
Br J Dermatol, 166 (6), 1342-8
PubMed 22309486

Wiegell SR, Fabricius S, Gniadecka M, Stender IM, Berne B, Kroon S, Andersen BL, Mørk C, Sandberg C, Ibler KS, Jemec GB, Brocks KM, Philipsen PA, Heydenreich J, Hædersdal M, Wulf HC (2012)
Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study
Br J Dermatol, 166 (6), 1327-32
PubMed 22250644

Publications 2011

Christensen E, Mørk C, Foss OA (2011)
Pre-treatment deep curettage can significantly reduce tumour thickness in thick Basal cell carcinoma while maintaining a favourable cosmetic outcome when used in combination with topical photodynamic therapy
J Skin Cancer, 2011, 240340
PubMed 22191035

Ljosaa TM, Mork C, Stubhaug A, Moum T, Wahl AK (2011)
Skin pain and skin discomfort is associated with quality of life in patients with psoriasis
J Eur Acad Dermatol Venereol, 26 (1), 29-35
PubMed 21385220

Wiegell SR, Fabricius S, Stender IM, Berne B, Kroon S, Andersen BL, Mørk C, Sandberg C, Jemec GB, Mogensen M, Brocks KM, Philipsen PA, Heydenreich J, Haedersdal M, Wulf HC (2011)
A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp
Br J Dermatol, 164 (5), 1083-90
PubMed 21219287

Publications 2010

Cicarma E, Mørk C, Porojnicu AC, Juzeniene A, Tam TT, Dahlback A, Moan J (2010)
Influence of narrowband UVB phototherapy on vitamin D and folate status
Exp Dermatol, 19 (8), e67-72
PubMed 19849714

Ljosaa TM, Rustoen T, Mörk C, Stubhaug A, Miaskowski C, Paul SM, Wahl AK (2010)
Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics
Acta Derm Venereol, 90 (1), 39-45
PubMed 20107724

Preus HR, Khanifam P, Kolltveit K, Mørk C, Gjermo P (2010)
Periodontitis in psoriasis patients: a blinded, case-controlled study
Acta Odontol Scand, 68 (3), 165-70
PubMed 20141361

Publications 2009

Bergersen TK, Mørk C (2009)
[A 62-year-old woman with non-pitting leg oedema]
Tidsskr Nor Laegeforen, 129 (8), 750-2
PubMed 19373301

Christensen E, Warloe T, Kroon S, Funk J, Helsing P, Soler AM, Stang HJ, Vatne O, Mørk C, Norwegian Photodynamic Therapy (PDT) Group (2009)
Guidelines for practical use of MAL-PDT in non-melanoma skin cancer
J Eur Acad Dermatol Venereol, 24 (5), 505-12
PubMed 19807828

Publications 2008

Wennberg AM, Stenquist B, Stockfleth E, Keohane S, Lear JT, Jemec G, Mork C, Christensen E, Kapp A, Solvsten H, Talme T, Berne B, Forschner T (2008)
Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study
Transplantation, 86 (3), 423-9
PubMed 18698246

Publications 2006

Krogstad AL, Mork C, Piechnik SK (2006)
Daily pattern of sweating and response to stress and exercise in patients with palmar hyperhidrosis
Br J Dermatol, 154 (6), 1118-22
PubMed 16704643

Wahl AK, Mørk C, Hanestad BR, Helland S (2006)
Coping with exacerbation in psoriasis and eczema prior to admission in a dermatological ward
Eur J Dermatol, 16 (3), 271-5
PubMed 16709492

Wahl AK, Mørk C, Lillehol BM, Myrdal AM, Helland S, Hanestad BR, Moum T (2006)
Changes in quality of life in persons with eczema and psoriasis after treatment in departments of dermatology
Acta Derm Venereol, 86 (3), 198-201
PubMed 16710574

Walberg M, Mørk C, Sandven P, Jorde AT, Bjørås M, Gaustad P (2006)
18S rDNA polymerase chain reaction and sequencing in onychomycosis diagnostics
Acta Derm Venereol, 86 (3), 223-6
PubMed 16710579

Publications 2005

Davidsson S, Blomqvist K, Molin L, Mørk C, Sigurgeirsson B, Zachariae H, Zachariae R (2005)
Lifestyle of Nordic people with psoriasis
Int J Dermatol, 44 (5), 378-83
PubMed 15869535

Wahl AK, Mørk C, Cooper BA, Padilla G (2005)
No long-term changes in psoriasis severity and quality of life following climate therapy
J Am Acad Dermatol, 52 (4), 699-701
PubMed 15793527

Publications 2004

Mørk C, Ozek M, Wahl AK (2004)
[Psoriasis and psoriatic arthritis--is climate therapy a treatment or a leisure activity?]
Tidsskr Nor Laegeforen, 124 (1), 60-2
PubMed 14716397

Mørk C, Salerud EG, Asker CL, Kvernebo K (2004)
The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia-a double-blind, crossover, placebo-compared study
J Invest Dermatol, 122 (3), 587-93
PubMed 15086539

Orstavik K, Mørk C, Kvernebo K, Jørum E (2004)
Pain in primary erythromelalgia--a neuropathic component?
Pain, 110 (3), 531-8
PubMed 15288393

Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B (2004)
Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers
J Eur Acad Dermatol Venereol, 18 (1), 27-36
PubMed 14678528

Publications 2003

Kalgaard OM, Mørk C, Kvernebo K (2003)
Prostacyclin reduces symptoms and sympathetic dysfunction in erythromelalgia in a double-blind randomized pilot study
Acta Derm Venereol, 83 (6), 442-4
PubMed 14690340

Publications 2002

Mørk C, Kalgaard OM, Kvernebo K (2002)
Impaired neurogenic control of skin perfusion in erythromelalgia
J Invest Dermatol, 118 (4), 699-703
PubMed 11918719

Mørk C, Kvernebo K, Asker CL, Salerud EG (2002)
Reduced skin capillary density during attacks of erythromelalgia implies arteriovenous shunting as pathogenetic mechanism
J Invest Dermatol, 119 (4), 949-53
PubMed 12406343

Mørk C, Wahl A (2002)
Improved quality of life among patients with psoriasis after supervised climate therapy at the Canary Islands
J Am Acad Dermatol, 47 (2), 314-6
PubMed 12140483

Mørk C, Wahl A, Moum T (2002)
The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics
Acta Derm Venereol, 82 (5), 347-51
PubMed 12430733

Zachariae H, Zachariae R, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B (2002)
Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study
Acta Derm Venereol, 82 (2), 108-13
PubMed 12125937

Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B (2002)
Quality of life in 6497 Nordic patients with psoriasis
Br J Dermatol, 146 (6), 1006-16
PubMed 12072069

Publications 2001

Zachariae H, Zachariae R, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B (2001)
Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study
Acta Derm Venereol, 81 (2), 116-21
PubMed 11501648

Publications 2000

Mork C, Asker CL, Salerud EG, Kvernebo K (2000)
Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia
J Invest Dermatol, 114 (4), 643-6
PubMed 10733667

Mork C, Kvernebo K (2000)
Mechanisms other than shunting are likely contributing to the pathophysiology of erythromelalgia - Reply
J. Invest. Dermatol., 115 (6), 1167

Mørk C, Kalgaard OM, Myrvang B, Kvernebo K (2000)
Erythromelalgia in a patient with AIDS
J Eur Acad Dermatol Venereol, 14 (6), 498-500
PubMed 11444274

Mørk C, Kvernebo K (2000)
Erythromelalgia--a mysterious condition?
Arch Dermatol, 136 (3), 406-9
PubMed 10724206

Publications 1999

Mørk C (1999)
[Who shall be treated for excessive sweating and how?]
Tidsskr Nor Laegeforen, 119 (2), 178
PubMed 10081345

Mørk C, Kalgaard OM, Kvernebo K (1999)
Erythromelalgia as a paraneoplastic syndrome in a patient with abdominal cancer
Acta Derm Venereol, 79 (5), 394
PubMed 10494725

Strømme P, Sundet K, Mørk C, Cassiman JJ, Fryns JP, Claes S (1999)
X linked mental retardation and infantile spasms in a family: new clinical data and linkage to Xp11.4-Xp22.11
J Med Genet, 36 (5), 374-8
PubMed 10353782

Publications 1997

Mørk C (1997)
[Hair loss. Causes, diagnosis, clinical manifestations and treatment]
Tidsskr Nor Laegeforen, 117 (21), 3103-6
PubMed 9381446

Publications 1992

Mörk C (1992)
[Here is New Ventures!]
Vardfacket, 16 (17), 4
PubMed 1300843

Publications 1991

Braathen LR, Ramirez G, Kunze RO, Mork C, Strand O (1991)
Latent infection of epidermal Langerhans cells in HIV-positive individuals
Res Virol, 142 (2-3), 119-21
PubMed 1896635

Mørk C, Gabrielsen TO (1991)
[Cowden's disease. A syndrome with multiple hamartomas and neoplasias]
Tidsskr Nor Laegeforen, 111 (19), 2432-4
PubMed 1926083

Publications 1990

Mörk C (1990)
[Focus on work environment. The soul fares ill when the work environment is poor]
Vardfacket, 14 (20), 24
PubMed 2096545

Mørk C, van Deurs B, Petersen OW (1990)
Regulation of vimentin expression in cultured human mammary epithelial cells
Differentiation, 43 (2), 146-56
PubMed 2373288

Publications 1988

Jensen P, Leite K, Lützow-Holm C, Mørk C, Steinkjer B, Søyland E (1988)
[Consultation analysis in hospitals. Experiences of an educational program in communication with patients]
Tidsskr Nor Laegeforen, 108 (32), 2957-8
PubMed 3252539

Mørk C, Braathen LR (1988)
[Minoxidil--a hope for patients with androgen alopecia?]
Tidsskr Nor Laegeforen, 108 (28), 2391-3
PubMed 3061060

Mørk C, Braathen LR (1988)
[Androgenic alopecia]
Tidsskr Nor Laegeforen, 108 (28), 2388-90
PubMed 3206449

Publications 1987

Holmertz V, Mörk C, Stubbendorff S, Thomasson J, Trozell M (1987)
[Dialysis accidents--4 years after. Who takes responsibility when safety is lacking? Worried members interrupt work]
Vardfacket, 11 (22), 4-6
PubMed 3442122

Mørk C, Braathen LR (1987)
[Iontophoresis in the treatment of hyperhidrosis]
Tidsskr Nor Laegeforen, 107 (16), 1468-9
PubMed 3603515